Evidence map›Paper›PMID 26966512›Full record

ReviewToxicology research2013

Novel

Dominic P Williams, Rebecca Shipley, Marianne J Ellis, Steve Webb, John Ward, Iain Gardner, Stuart Creton

Open access · bronzeAbstract readReview
In one paragraph

Review in Toxicology research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 46 citations in OpenAlex.

  1. AI/ML-based computational models for toxicity prediction.Environmental science and pollution research international · 2026
    Review
  2. Review
  3. Article
  4. Characterisation of a functional rat hepatocyte spheroid model.Toxicology in vitro : an international journal published in association with BIBRA · 2019
    Article
  5. Frontiers in bioengineering and biotechnology · 2019
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  11. Article
  12. Toxicological research · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 2 countries.

Dominic P WilliamsMRC Centre for Drug Safety Science , Department of Molecular and Clinical Pharmacology , Institute of Translational Medicine , The University of Liverpool , Sherrington Building , Ashton St. , Liverpool , L69 3GE , UK . Email: dom@liv.ac.uk ; ; Tel: +44 (0)151 794 5791.
Rebecca ShipleyDepartment of Mechanical Engineering , University College London , Torrington Place , London WC1E 7JE , UK.
Marianne J EllisDepartment of Chemical Engineering , University of Bath , Claverton Down , Bath , BA2 7AY , UK.
Steve WebbDepartment of Mathematics and Statistics , University of Strathclyde , Livingstone Tower , 26 Richmond Street , Glasgow , G1 1XH , UK.
John WardSchool of Mathematical Sciences , Loughborough University , Loughborough , LE11 3TU , UK.
Iain GardnerSimcyp Limited , Blades Enterprise Centre , John Street , Sheffield S2 4SU , UK.
Stuart CretonNC3Rs Gibbs Building , 215 Euston Road , London , NW1 2BE , UK.
Loughborough University · GBNational Centre for the Replacement Refinement and Reduction of Animals in Research · GBSimcyp (United Kingdom) · GBTorrington Hospital · GBUniversity of Bath · GBUniversity of Liverpool · GBUniversity of Strathclyde · GB

Funding

National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/C011205/1
6 · The paper itself

Abstract

The focus of much scientific and medical research is directed towards understanding the disease process and defining therapeutic intervention strategies. The scientific basis of drug safety is very complex and currently remains poorly understood, despite the fact that adverse drug reactions (ADRs) are a major health concern and a serious impediment to development of new medicines. Toxicity issues account for ∼21% drug attrition during drug development and safety testing strategies require considerable animal use. Mechanistic relationships between drug plasma levels and molecular/cellular events that culminate in whole organ toxicity underpins development of novel safety assessment strategies. Current

Identifiers

PMID26966512
PMCPMC4765367
OpenAlexW2065096141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.